Abstract
Objectives
To determine whether subconjunctival Mitomycin-C (MMC) injections are as safe and effective as sponge-soaked MMC in phaco-trabeculectomy.
Methods
This prospective, randomized, interventional study was conducted on consecutive patients with visually significant cataract and an uncontrolled primary open-angle glaucoma. One hundred thirty-nine patients were recruited but 15 were ineligible for analysis. The patients were randomized into a sponge/injection group. All participants received a twin-site phaco-trabeculectomy. They were followed up on days 1, 15, 30, 3 months and 6 months post-operatively. A p-value < 0.05 was considered significant.
Interventions
Participants in the sponge group received an augmentation of their phaco-trabeculectomy with sponges soaked in a mixture of 0.04% MMC and 2% preservative-free Lignocaine in a 1:1 ratio, placed in the subconjunctival space for four minutes. Participants in the injection group received the same mixture as a subconjunctival injection, after surgical draping.
Results
There were 62 patients in each group. The groups had no significant differences in their baseline characteristics. The mean IOP at 6 months was significantly lower in the injection group (14.8 ± 3.7 mm Hg) than in the sponge group (17.1 ± 6.4 mm Hg) (p = 0.02). There was no notable difference in the complications or the final post-operative visual outcome but a significantly greater number of patients in the sponge arm required removal of the releasable suture (p = 0.001) and additional anti-glaucoma medications (p = 0.04) at six months post-operatively.
Conclusions
Subconjunctival MMC achieves a lower IOP with fewer anti-glaucoma medications than sponge-soaked MMC at six months for twin-site phaco-trabeculectomy in primary open-angle glaucoma with no additional risks.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The dataset analyzed during the current study has not been uploaded into a repository but will be available from the corresponding author on reasonable request approved by the Tirunelveli Medical College Institutional Research Ethics Committee and Aravind Eye Hospital & PG Institute of Ophthalmology, Tirunelveli.
References
Al Habash A, Aljasim LA, Owaidhah O, Edward DP. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin Ophthalmol. 2015;9:1945–51.
Urbaneja D, Morilla-Grasa A, Jimenez E, Montemayor J, Marcobal N, Aragay C, et al. In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery. Clin Ophthalmol. 2016;10:665–9.
Khamar M, Bhojwani D, Patel P, Vasavada A. Leftover mitomycin-c sponge causing blebitis. Indian J Ophthalmol. 2019;67:1753–5.
Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV, et al. Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Surv Ophthalmol. 2021;66:109–23.
Kandarakis SA, Papakonstantinou E, Petrou P, Diagourtas A, Ifantides C, Georgalas I, et al. One-year randomized comparison of safety and efficacy of trabeculectomy with mitomycin C sub-tenon injection versus mitomycin C-infused sponges. Ophthalmol Glaucoma. 2022;5:77–84.
Lee E, Doyle E, Jenkins C. Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C. Acta Ophthalmol. 2008;86:866–70.
Do JL, Xu BY, Wong B, Camp A, Ngai P, Long C, et al. A randomized controlled trial comparing subconjunctival injection to direct scleral application of mitomycin C in trabeculectomy. Am J Ophthalmol. 2020;220:45–52.
Hung PT. Mitomycin-C in glaucoma filtering surgery. Asia Pac Ophthalmol. 2000;2:21–4.
Maheshwari D, Kanduri S, Rengappa R, Kadar MA. Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: one-year study. Indian J Ophthalmol. 2020;68:615–9.
Chiew W, Guo X, Ang BCH, Lim APH, Yip LWL. Comparison of surgical outcomes of sponge application versus subconjunctival injection of mitomycin-C during combined phacoemulsification and trabeculectomy surgery in asian eyes. J Curr Ophthalmol. 2021;33:253–9.
Khouri AS, Huang GY, Huang L. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: one-year study. J Curr Glaucoma Pract. 2017;11:101–6.
Esfandiari H, Pakravan M, Yazdani S, Doozandeh A, Yaseri M, Conner IP. Treatment outcomes of mitomycin C-augmented trabeculectomy, sub-tenon injection versus soaked sponges, after 3 years of follow-up: a randomized clinical trial. Ophthalmol Glaucoma. 2018;1:66–74.
Ahmadzadeh A, Kessel L, Subhi Y, Bach-Holm D. Comparative efficacy of phacotrabeculectomy versus trabeculectomy with or without later phacoemulsification: a systematic review with meta-analyses. J Ophthalmol. 2021;2021:6682534.
Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305–10.
Ogata-Iwao M, Inatani M, Takihara Y, Inoue T, Iwao K, Tanihara H. A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C. Acta Ophthalmol. 2013;91:e500–1.
Kleinmann G, Katz H, Pollack A, Schechtman E, Rachmiel R, Zalish M. Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation. Ophthalmic Surg Lasers. 2002;33:102–8.
Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol. 2003;87:850–2.
Sacchi M, Monsellato G, Villani E, Lizzio RAU, Cremonesi E, Luccarelli S, et al. Intraocular pressure control after combined phacotrabeculectomy versus trabeculectomy alone. Eur J Ophthalmol. 2022;32:327–35.
Mostafaei A. Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial. Clin Ophthalmol. 2011;5:491–4.
Singh J, O’Brien C, Chawla HB. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye. 1995;9:460–6.
Lee JWY, Lai JSM, Yick DWF, Tse RKK. Retrospective case series on the long-term visual and intraocular pressure outcomes of phacomorphic glaucoma. Eye. 2010;24:1675–80.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Cochran WG. Some methods for strengthening the common χ2 tests. Biometrics. 1954;10:417–51.
Wong JKW, Leung TK, Lai JS, Chan JC. Evaluation of adverse effects of topical glaucoma medications on trabeculectomy outcomes using the glaucoma medications intensity index. Ophthalmol Ther. 2022;11:387–401.
Husain R, Liang S, Foster PJ, Gazzard G, Bunce C, Chew PTK, et al. Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Arch Ophthalmol. 2012;130:165–70.
Siriwardena D, Kotecha A, Minassian D, Dart J, Khaw P. Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol. 2000;84:1056–7.
Cabourne E, Clarke JCK, Schlottmann PG, Evans JR. Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015;2015:CD006259.
Farooq S, Farooq H, Faisal M. Outcome of intraoperative Mitomycin C injection in trabeculectomy and phacotrabeculectomy in patients with glaucoma. Pak J Ophthalmol. 2021;37:213–7.
Guimarães ME, de Pádua Soares Bezerra B, de Miranda Cordeiro F, Carvalho CH, Danif DN, Prata TS, et al. Glaucoma surgery with soaked sponges with Mitomycin C vs sub-tenon injection: short-term outcomes. J Curr Glaucoma Pr. 2019;13:50–4.
Murthy SK, Damji KF, Pan Y, Hodge WG. Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. Can J Ophthalmol. 2006;41:51–9.
Bindlish R, Condon GP, Schlosser JD, D’Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology. 2002;109:1336–41.
Janani MK, Jaichandran V, Madhavan HNR, Vijaya L, George RJ, Ambastha PS, et al. Effect of lignocaine concentration on human fibroblasts growth in eyes undergoing trabeculectomy: an in vitro study. Biomed Hub. 2018;3:1–10.
Klifto MR, Fleischman D. pH of Mitomycin-C formulations for filtration surgery. J Glaucoma. 2019;28:647–8.
Park A, Hardin JS, Bora NS, Morshedi RG. Effects of lidocaine on mitomycin C cytotoxicity. Ophthalmol Glaucoma. 2021;4:330–5.
Mietz H, Diestelhorst M, Rump AF, Theisohn M, Klaus W, Krieglstein GK. Ocular concentrations of mitomycin C using different delivery devices. Ophthalmologica. 1998;212:37–42.
Sacu S, Rainer G, Findl O, Georgopoulos M, Vass C. Correlation between the early morphological appearance of filtering blebs and outcome of trabeculectomy with mitomycin C. J Glaucoma. 2003;12:430–5.
Lim MC, Hom B, Watnik MR, Brandt JD, Altman AR, Paul T, et al. A comparison of trabeculectomy surgery outcomes with Mitomycin-C applied by intra-tenon injection versus sponge. Am J Ophthalmol. 2020;216:243–56.
Mokbel TH, Ghanem AA, Moawad AI, Nafie EM, Nematallah EH. Comparative study of phacoemulsification-subscleral trabeculectomy versus phacoemulsification-deep sclerectomy. Saudi J Ophthalmol. 2009;23:189–96.
Reps JM, Rijnbeek P, Cuthbert A, Ryan PB, Pratt N, Schuemie M. An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design. BMC Med Inf Decis Mak. 2021;21:43.
Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJ. Selection bias due to loss to follow up in cohort studies. Epidemiology. 2016;27:91–7.
Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19–26.
Wells AP, Crowston JG, Marks J, Kirwan JF, Smith G, Clarke JCK, et al. A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma. 2004;13:454–60.
Cantor LB, Mantravadi A, WuDunn D, Swamynathan K, Cortes A. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale. J Glaucoma. 2003;12:266–71.
Smith M, Chipman ML, Trope GE, Buys YM. Correlation between the indiana bleb appearance grading scale and intraocular pressure after phacotrabeculectomy. J Glaucoma. 2009;18:217–9.
Author information
Authors and Affiliations
Contributions
SC was responsible for drafting the protocol, reviewing literature, extracting and analyzing data, interpreting the results, writing the manuscript and generating the tables and the graphs. MAK and DM were responsible for designing the study protocol, interpreting the results, and providing feedback on the manuscript. MRP, SkC and RR helped in interpreting the results and provided feedback on the manuscript. All authors approved the submitted version of the manuscript and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chakrabarty, S., Kader, M.A., Maheshwari, D. et al. Short-term outcomes of Mitomycin-C augmented phaco-trabeculectomy using subconjunctival injections versus soaked sponges: a randomized controlled trial. Eye 38, 1196–1201 (2024). https://doi.org/10.1038/s41433-023-02869-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02869-2